|
|
Volumn 29, Issue SUPPL. 2, 1996, Pages 37-39
|
|
Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: The argument against
|
|
Author keywords
Anandron ; Antiandrogens; Bicalutamide; Casodex ; Combined androgen blockade; Eulexin ; Flutamide; Goserelin; Nilutamide; Prostate cancer; Zoladex
|
|
Indexed keywords
ANTIANDROGEN;
BICALUTAMIDE;
FLUTAMIDE;
GOSERELIN;
NILUTAMIDE;
ADVANCED CANCER;
CANCER MORTALITY;
CANCER SURVIVAL;
CASTRATION;
CONFERENCE PAPER;
HUMAN;
MALE;
META ANALYSIS;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTATE CANCER;
|
|
EID: 0029887921
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000473837 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (0)
|
